27 related articles for article (PubMed ID: 28427122)
1. Multiparameter Magnetic Resonance Quantitative Evaluation of Pancreatic Cancer with Vascular Invasion.
Zhou M; Wu Y; Yin L
Biomed Res Int; 2022; 2022():4370341. PubMed ID: 35496056
[TBL] [Abstract][Full Text] [Related]
2. The prognostic value of dynamic contrast-enhanced MRI contrast agent transfer constant K
Dickie BR; Rose CJ; Kershaw LE; Withey SB; Carrington BM; Davidson SE; Hutchison G; West CML
Br J Cancer; 2017 May; 116(11):1436-1443. PubMed ID: 28449009
[TBL] [Abstract][Full Text] [Related]
3. Fluid Mechanics Approach to Perfusion Quantification: Vasculature Computational Fluid Dynamics Simulation, Quantitative Transport Mapping (QTM) Analysis of Dynamics Contrast Enhanced MRI, and Application in Nonalcoholic Fatty Liver Disease Classification.
Zhang Q; Luo X; Zhou L; Nguyen TD; Prince MR; Spincemaille P; Wang Y
IEEE Trans Biomed Eng; 2023 Mar; 70(3):980-990. PubMed ID: 36107908
[TBL] [Abstract][Full Text] [Related]
4. The ISMRM Open Science Initiative for Perfusion Imaging (OSIPI): Results from the OSIPI-Dynamic Contrast-Enhanced challenge.
Shalom ES; Kim H; van der Heijden RA; Ahmed Z; Patel R; Hormuth DA; DiCarlo JC; Yankeelov TE; Sisco NJ; Dortch RD; Stokes AM; Inglese M; Grech-Sollars M; Toschi N; Sahoo P; Singh A; Verma SK; Rathore DK; Kazerouni AS; Partridge SC; LoCastro E; Paudyal R; Wolansky IA; Shukla-Dave A; Schouten P; Gurney-Champion OJ; Jiřík R; Macíček O; Bartoš M; Vitouš J; Das AB; Kim SG; Bokacheva L; Mikheev A; Rusinek H; Berks M; Hubbard Cristinacce PL; Little RA; Cheung S; O'Connor JPB; Parker GJM; Moloney B; LaViolette PS; Bobholz S; Duenweg S; Virostko J; Laue HO; Sung K; Nabavizadeh A; Saligheh Rad H; Hu LS; Sourbron S; Bell LC; Fathi Kazerooni A
Magn Reson Med; 2024 May; 91(5):1803-1821. PubMed ID: 38115695
[TBL] [Abstract][Full Text] [Related]
5. Analysis of Magnetic Resonance Imaging Perfusion Parameters for the Identification of Spinal Metastatic Tumors with Rich Blood Supply.
Guo GH; He QJ; Zhang XL; Jiao YQ; Wang M; Li FX
World Neurosurg; 2023 Dec; 180():e506-e513. PubMed ID: 37774790
[TBL] [Abstract][Full Text] [Related]
6. Correlation of Perfusion Metrics with Ki-67 Proliferation Index and Axillary Involvement as a Prognostic Marker in Breast Carcinoma Cases: A Dynamic Contrast-Enhanced Perfusion MRI Study.
Uncu UY; Aydin Aksu S
Diagnostics (Basel); 2023 Oct; 13(20):. PubMed ID: 37892081
[TBL] [Abstract][Full Text] [Related]
7. Distribution of Intravascular and Extravascular Extracellular Volume Fractions by Total Area under Curve for Neovascularization Assessment by Dynamic Contrast-Enhanced Magnetic Resonance Imaging.
Sun Y
J Med Signals Sens; 2014 Jul; 4(3):159-70. PubMed ID: 25298925
[TBL] [Abstract][Full Text] [Related]
8. A Novel Multi-Model High Spatial Resolution Method for Analysis of DCE MRI Data: Insights from Vestibular Schwannoma Responses to Antiangiogenic Therapy in Type II Neurofibromatosis.
Li KL; Lewis D; Zhu X; Coope DJ; Djoukhadar I; King AT; Cootes T; Jackson A
Pharmaceuticals (Basel); 2023 Sep; 16(9):. PubMed ID: 37765090
[TBL] [Abstract][Full Text] [Related]
9. Uterine Adenomatoid Tumor: A Great Imitator of Leiomyoma under Laparoscopy.
Chen SY; Yeh CJ; Pai AH; Mak KS; Kuo HH; Yen CF
Gynecol Minim Invasive Ther; 2023; 12(4):255-256. PubMed ID: 38034110
[No Abstract] [Full Text] [Related]
10. Estimating kinetic parameters from dynamic contrast-enhanced T(1)-weighted MRI of a diffusable tracer: standardized quantities and symbols.
Tofts PS; Brix G; Buckley DL; Evelhoch JL; Henderson E; Knopp MV; Larsson HB; Lee TY; Mayr NA; Parker GJ; Port RE; Taylor J; Weisskoff RM
J Magn Reson Imaging; 1999 Sep; 10(3):223-32. PubMed ID: 10508281
[TBL] [Abstract][Full Text] [Related]
11. Differential Diagnosis of Uterine Leiomyoma and Uterine Sarcoma using Magnetic Resonance Images: A Literature Review.
Suzuki A; Aoki M; Miyagawa C; Murakami K; Takaya H; Kotani Y; Nakai H; Matsumura N
Healthcare (Basel); 2019 Dec; 7(4):. PubMed ID: 31817500
[TBL] [Abstract][Full Text] [Related]
12. [Application on the quantitative perfusion parameters of dynamic contrast-enhanced MRI in the pathological subtype of uterine leiomyoma].
Zheng J; Zhao ZH; Yang JF; Zhao L; Yang LM; Hu HJ
Zhonghua Yi Xue Za Zhi; 2017 Apr; 97(15):1155-1159. PubMed ID: 28427122
[No Abstract] [Full Text] [Related]
13. Quantitative perfusion histogram parameters of dynamic contrast-enhanced MRI to identify different pathological types of uterine leiomyoma.
Wang S; Zhao Z; Zhang Y; Yang L; Huang Y; Ruan Y; Wang C
Zhejiang Da Xue Xue Bao Yi Xue Ban; 2021 Feb; 50(1):97-105. PubMed ID: 34117849
[TBL] [Abstract][Full Text] [Related]
14. [Application of dynamic-contrast enhanced magnetic resonance pharmacokinetic models in differential diagnosis of cellular uterine leiomyoma].
Wang S; Zhao Z; Hu H; Yang J; Zhao L; Yang L; Wang C
Zhejiang Da Xue Xue Bao Yi Xue Ban; 2017 May; 46(5):498-504. PubMed ID: 29488716
[TBL] [Abstract][Full Text] [Related]
15. The predictive value of quantitative DCE metrics for immediate therapeutic response of high-intensity focused ultrasound ablation (HIFU) of symptomatic uterine fibroids.
Wei C; Fang X; Wang CB; Chen Y; Xu X; Dong JN
Abdom Radiol (NY); 2018 Aug; 43(8):2169-2175. PubMed ID: 29204677
[TBL] [Abstract][Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
